<DOC>
	<DOCNO>NCT01003613</DOCNO>
	<brief_summary>Recurrent secondary pterygium often often grow fibrovascular tissue exuberant primary . Histological finding differ primary , since typical change degenerate connective tissue absent . The strong immunoreactivity release basic fibroblast growth ( b-FGF ) culture fibroblast recurrent pterygium suggest fibroblast may play important role pterygium recurrence . Tranilast use antiallergic drug inhibitory effect release chemical transmitter , histamine leukotrienes mast cell well suppressive effect vascular permeability.This drug also reduce TGF-β1 production collagen synthesis various cell . Tranilast might reduce pterygium recurrence suppress TGF-β1 synthesis conjunctival fibroblast pterygium surgery . The investigator want confirm finding also compare recurrence rate two type surgery . Tranilast might alternative mitomycin use , also less toxic . This study aim compare effectiveness prevent recurrence use tranilast topical subconjunctival administration previous conjunctival autograft transplantation surgery case primary pterygium , perform clinical evaluation TGF-beta-1 immunohistochemical detection anti-TGF-beta 1 antibody well fibroblast culture .</brief_summary>
	<brief_title>Evaluation Tranilast Treat Pterygium Before Excision</brief_title>
	<detailed_description>This prospective , randomised , control trial 50 participant . Twenty five patient arm . Twenty five patient undergo standard pterygium excision fibrin glue ( Tissucol ) conjunctival autograft . Twenty five patient undergo pterygium surgery fibrin glue ( Tissucol ) , subconjunctival injection 0.1 ml Tranilast 1.0 % head pterygium 30 day surgery . Participants review , select , consented pre-assessment day . Surgery perform 4 time day surgery operate list . Randomisation surgery type do time surgery pterygium excise autograft take . The surgery perform single surgeon ( Almeida Jr , GC ) . Follow-up occur week 1,4 , 26 , 52 . Slit lamp examination indicate pterygium recurrence . Corneal recurrence consider 0.5 mm invade conjunctival tissue , clear cornea anatomical limbus . The conjunctival recurrence consider size conjunctive fibrovascular invasion inside graft . The localization immunohistochemical perform TGF-B .</detailed_description>
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<mesh_term>Tranilast</mesh_term>
	<criteria>Primary pterygium Keratoconjunctivitis sicca Sjögren disease Vernal keratoconjunctivitis Acne rosacea Neurotrophic keratopathy Severe dysfunction meibomius gland Use immunosuppressive drug , systemic topical route Aged 18 year age vulnerable group Glaucoma use ocular hipotensor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Tranilast</keyword>
	<keyword>fibrin glue</keyword>
	<keyword>primary pterygium</keyword>
	<keyword>conjunctival autograft</keyword>
</DOC>